Combination Chemotherapy in Treating Patients With Multiple Myeloma
Status:
Completed
Trial end date:
2004-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy consisting of
liposomal doxorubicin, vincristine, and dexamethasone in treating patients with newly
diagnosed or previously treated multiple myeloma.